HalioDx
Latest round
- Series B
Last raised
- Feb 2018
Total raised
- $12M
Investors
- 7
About HalioDx
HalioDx SAS, founded in 2015 in Marseille, France, focuses on genomic analysis for precision medicine.249 mn. The firm has completed a total of 3 deals to date. Jerome Galon, the founder, has a notable background in genomics and previously contributed to advancements in cancer diagnostics and treatments. The firm was recently acquired by Veracyte, Inc.HalioDx specializes in providing advanced genomic and biomarker analysis services that cater to a diverse range of clients in the healthcare and life sciences sectors. Their core offerings include innovative solutions for precision medicine, diagnostic testing, and drug discovery, leveraging technology to deliver reliable insights. The company focuses on addressing challenges in personalized healthcare, enabling providers to utilize genomic data to improve patient outcomes.40.HalioDx plans to expand its product offerings and enter new markets. The company is focusing on developing new diagnostic tools and solutions aimed at enhancing precision medicine capabilities.249 mn, HalioDx intends to invest in research and development, targeting expansion in North America and Europe by 2023 to meet the increasing demand for advanced diagnostic services. The acquisition by Veracyte, Inc. will also facilitate HalioDx’s growth trajectory, enabling access to a broader range of resources and networks in the healthcare sector.
Who invested in HalioDx
7 investors across 1 round
See all investors in HalioDx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Feb 2, 2018
Amount
$12M
Investors
Questions about HalioDx
Who invested in HalioDx?
HalioDx has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has HalioDx raised?
HalioDx has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did HalioDx last raise money?
HalioDx's most recent round on record is a Series B, in Feb 2018.
What does HalioDx do?
HalioDx SAS, founded in 2015 in Marseille, France, focuses on genomic analysis for precision medicine.
Where is HalioDx headquartered?
HalioDx is headquartered in Marseille, France.
Which VCs invest in companies like HalioDx?
Among active investors with capital left to deploy, Index Ventures, Forbion, Balderton Capital and Sofinnova Partners back healthcare companies at HalioDx's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like HalioDx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.